The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). One of the leading cannabis clinicians in the U.S.,

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. A systematic review published in 2017 aimed to identify available data about the therapeutic effect of cannabinoids treatment in children and adolescents.

Safety 52

Safety Cannabinoids Events Data 52

Canna Law Blog

DECEMBER 16, 2021

Expansive List of Qualifying Medical Conditions. Data from the RAND Corporation show that 8,000 New York veterans from the Wars in Iraq and Afghanistan suffer from PTSD. The FDA recognizes psilocybin therapy as substantially better than present treatment options.

Legislation 96

Legislation Treatment Therapy Conditions 96

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

CannaTech

SEPTEMBER 16, 2018

These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Similar frameworks exist across the world, presenting the same set of challenges Canada has faced along the way. It’s simply a matter of getting this information into the hands of both patients and doctors.

Education 66

Education Medicine Clinical Trials Patients 66

The Joint Blog

JANUARY 23, 2020

. “Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known.”

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74

The Joint Blog

JULY 14, 2021

There has been inadequate research conducted and not enough data that fully supports the use of CBD for the elderly. Older people with underlying conditions such as kidney disease, liver disease, epilepsy, weak immune system, and heart issues should mention it to the doctor before using CBD.

Medicine 52

Medicine CBD Chronic Pain Blood Pressure 52

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. School: Tufts University.

Research and Development 117

Research and Development Education Agriculture Patients 117

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

CannaMD

AUGUST 19, 2020

The CDC notes that individuals of all ages may contract COVID-19; however, the risk of death is significantly higher for older populations and those with underlying health conditions. While future research is needed, the present study opens up a new landscape for marijuana research – focusing on terpenes just as much as cannabinoids.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

FEBRUARY 17, 2020

” These necessary individuals present the finished state-certified cannabis product on the dispensary’s shelves in an appealing manner. On the popular MarijuanaDoctors.com , all qualifying conditions in Florida are noted. –Medical conditions of the same kind or class as or comparable to those above. .

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

OCTOBER 26, 2021

President, Director and Chief Medical Officer of MyMD, will be honored by the Arthritis Foundation as its Medical Honoree of 2021, to be presented at the annual Commitment to a Cure Gala being held October 28, 2021, in Washington, D.C. “I 1 Data published by Research and Markets, March 2018. MyMD: Robert Schatz. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JANUARY 20, 2022

The transaction is expected to close in the second or third quarter of 2022, subject to customary closing conditions, including the receipt of regulatory approvals and approval by SPKB’s shareholders. Investor Presentation Information. Eleusis and Silver Spike have prepared a prerecorded investor presentation.

Therapy 52

Therapy Research and Development Business Access 52

Ellementa

NOVEMBER 4, 2019

CBD research shows it can be effective in treating severe forms of epilepsy such as Dravet syndrome and Lennox-Gastaut syndrome (LGS). If you’re thinking about using CBD to address specific health conditions, as with any cannabis medicine, “start low and go slow.” Our Presenting Sponsor is TruPotency.

CBD 14

CBD Tincture Blood Pressure THC 14

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

JUNE 29, 2021

Sometimes the next-most abundant compounds can present a rich variability or even be more chemically active. It’s also the most appropriate for medical conditions such as depression , epilepsy , and autism spectrum disorder. Chemovars need to be further researched, and clustered in groups for specific conditions.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating. CBG vs. CBD.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating. CBG vs. CBD.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development THC 52

Cannabis Law Report

MAY 17, 2019

Because it can’t be sold between the states and is presently incapable of entering the stream of interstate commerce, the Marijuana industry has been spared the FDA’s scrutiny. Third, what does this portend for cannabis?

Food 10

Food DEA Hemp CBD 10

SMPL

MAY 26, 2020

Within a couple of years, they figured out a 1:1 combination of a high-THC chemovar and a high-CBD chemovar presented the greatest latitude of effects and prevention of side effects,” said Dr. Ethan Russo, who worked with GW Pharmaceuticals from 1998 to 2014. Watson and Mr. Clarke’s collection of cannabis and got to work.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 13, 2018

It is the most commonly identified cause of epilepsy among adults. These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. million Americans annually. Neurogenesis enhances motor function and overall recovery after TBI.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

It is the most commonly identified cause of epilepsy among adults. These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”. million Americans annually. Neurogenesis enhances motor function and overall recovery after TBI.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

NOVEMBER 22, 2019

Arizona regulators will stop issuing physical medical cannabis patient cards as of December 1 and will instead issue documents via email, that can be presented on a mobile phone or printed out. The study will use Connecticut-grown cannabis in a pill form to explore its effects on pain and stress-related conditions.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40